Algorae Pharmaceuticals LimitedASX: 1AI

Algorae executes Licence & Supply Agreement with Umedica

· Issued by Algorae Pharmaceuticals Limited via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Algorae Pharmaceuticals Limited has announced the execution of a Memorandum of Understanding and a Licence & Supply Agreement with Umedica Laboratories for the Australian pharmaceutical market. Under these agreements, AlgoraeRx will act as Umedica's exclusive importer and distributor in Australia for a range of products, while also commercializing them under its own brand. The product dossier has been submitted for regulatory approval to the Therapeutic Goods Administration.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/algorae-executes-licence-and-supply-agreement-with-umedica-1

Release

Algorae Pharmaceuticals Limited [ABN: 14 104 028 042] Level 23, Rialto South Tower, 525 Collins St, Melbourne VIC 3000 ASX ANNOUNCEMENT ASX: 1AI | 19 October 2026 Algorae executes MOU and Licence & Supply Agreement with Umedica for the Australian pharmaceutical market Highlights ? AlgoraeRx...

Algorae Pharmaceuticals Limited on 6ix

Story so far

Earlier from Algorae Pharmaceuticals

Later from Algorae Pharmaceuticals

All Algorae Pharmaceuticals news releases